A quantitative analysis was developed for the determination of cocaine, benzoylecgonine, and cocaethylene in oral fluid using liquid chromatography-tandem mass spectrometry. After internal standardization and solid-phase extraction, chromatographic separation was achieved on a reversed-phase column by gradient elution. Good linearity was obtained from 10 to 1000 pg/L. Extraction recoveries exceeded 85 % for all compounds. Excellent total and within-run reproducibilities (CV% < 20%) and accuracy figures were obtained. The limit of detection (signal-to-noise ratio > 3) was 1 pg/L for all three compounds. As such, a method for drug abuse confirmation analysis in oral fluid, compatible with the present day saliva collecting devices, is obtained. The method was applied to real samples (n = 15) obtained from suspected drug users, of which seven proved positive. The concentrations found in the positive samples were between 10.2 and 200.6 pg/t for cocaine, < limit of quantification (LOQ) and 10.5 pg/L for cocaethylene, and < LOQ and 59.2 pg/t for benzoylecgonine.
Introduction
Cocaine, an alkaloid from the plant Erythroxylon coca, is one of the most used drugs of abuse. It is snorted, injected, or smoked as "free base" but mainly as "crack". Cocaine is rapidly and almost completely metabolized and deactivated to ben-* Author to whom correspondence should be addressed.
zoylecgonine, ecgonine methyl ester, and ecgonine by esterases and spontaneous hydrolysis (1) . Benzoylecgonine, an inactive metabolite, nevertheless is, because of its longer half-life than cocaine, of considerable toxicological importance. Cocaethylene is an active homologue arising through transesterification following concomitant use of cocaine and ethanol. It shares many neurological and behavioral properties with cocaine and can reach significant blood concentrations (2) .
For the past two decades, there has been a great deal of interest in oral fluid as a potential biomatrix for drug testing (3) . Oral fluid analysis can be used for roadside testing (4), workplace drug testing (5) , measurement of therapeutic drugs (6) (7) , and the monitoring of patients (addicts) on maintenance programs (8) . The advantages of using oral fluid include the noninvasive nature of collection, without incursion into the privacy of the suspect. Moreover, oral fluid is easy to collect, and sampiing may be performed by nonmedical personnel (9) . Because the sampling can be observed closely without concern about the violation of privacy, it is less likely that the common methods of sample adulteration used in urine analysis could be easily applied to oral fluid (10). Last but not least, oral fluid is the only body fluid that has been successfully used as an alternative to blood in several pharmacokinetic and pharmacotoxicologic studies. There is evidence that when a given drug is detected in salivary specimens, a high likelihood exists that the individual tested is under the pharmacologic effects of the drug (11) .
The disadvantages associated with oral fluid sampling are limited sample size compared to urine, the variable nature of oral fluid pH influencing the partitioning into saliva (12) . Other considerations are the influence of collection devices on drug concentration and the possibility of oral fluid being contaminated with drug residues in the oral and nasal cavity (13) . However, several publications have proven useful correlations among the concentration levels of cocaine and metabolites in oral fluid with those encountered in blood and urine samples (13) (14) (15) (16) (17) . Such correlations proved, however, only useful provided potential buccal contamination is taken into consideration when collection takes place in the period immediately after the oral intake/smoking of the drugs (17) .
The first step in oral fluid testing is inevitably the collection of the oral fluid sample by a suitable sample collection device. This step is most of the time followed by an initial screening of the samples. This screening is generally performed with an immunological method, which is a useful approach to estimate, in our case, cocaine concentration. Nevertheless, it cannot be considered a reliable quantitative assay. A completely new and seemingly very promising screening approach using phosphorimetry has recently been described (10) . Screening methods have the merit of being fast and automated, but positive results should be confirmed, preferably by a different analytical principle. For such confirmation purposes, the analytical procedure described here was developed. Such a method has to fulfill the following requirements: reliability, especially if one thinks of the legal consequences. A conviction for drug abuse can have serious consequences. Another requirement is sensitivity, there is a need to analyze low concentrations in low sample volumes. If possible, a minimum of sample pretreatment is also preferred to guarantee a high enough sample throughput. These three demands have led us to the use of liquid chromatography-tandem mass spectrometry (LC-MS-MS). LC-MS(-MS), although being a very powerful technique (sensitive, fast, no need for derivatization), has as yet rarely been applied for the analysis of oral fluid (18, 19) .
Materials and Methods

Apparatus
The MS analyses were carried out on a Micromass quadrupole time-of-flight (Q-TOF) hybrid MS (Micromass, Manchester, U.K.) equipped with an orthogonal electrospray source (Z-sprayTM), which was operated in the positive ion mode. A Waters Alliance 2790 separation module (Waters, Milford, MA) was integrated with the Q-TOF instrument. Both the pump and the mass spectrometer were controlled by Masslynx software.
Reagents
All reagents and chemicals were of analytical grade and were from Aldrich (Gillingham, U.K.), unless stated otherwise. Solvents were of liquid chromatography (HPLC) grade from Fisher Scientific (Loughborough, U.K.) or Merck (Darmstadt, Germany). The benzoylecgonine, cocaine, and cocaethylene pure standards were from Sigma (St. Louis, MO). The internal standards (IS) 2'-methylbenzoylecgonine (used for benzoylecgonine) and 2'-methylcocaine (IS2, used for cocaine and cocaethylene) were synthesized and characterized by us following an earlier described procedure (20) . Stock solutions (1.0 mg/mL) of these active substances were prepared in methanol. Dilution with methanol yielded the working solutions at appropriate concentrations either to be used as such or to prepare spiked calibration samples in the oral fluid. All these solutions were stored in the freezer (-20~ and proved stable for at least six months.
Extraction
Mixed-mode silica solid-phase extraction (SPE) cartridges were used for the extraction of cocaine and metabolites from the oral fluid samples. After addition of the internal standard (50 pL of a 5 ng/50 IJL solution of ISt and IS2) to 100 tJL oral fluid, the sample was diluted with 1 mL doubly distilled water and 1 mL phosphate buffer (0.1M, pH 6). After conditioning of the SPE columns (IST TM confirm HCX, 130 mg/3 mL, Hengoed, U.K.) with 3 mL methanol, followed by 3 mL phosphate buffer (0.1M, pH 6), the sample was applied on the extraction column. Subsequently, the columns were washed with 3 mL water and 3 mL 0.1M hydrochloric acid. After 2 rain of drying time, 3 mL methanol and 3 mL acetonitrile were pulled through the column. After thorough drying of the bed, the columns were finally eluted 2x with 1.5 mL freshly preparated elution mixture (i-propanol/CH2Cl2/NH4OH, 20:78:2, v/v). These extracts were evaporated to dryness with nitrogen using a Zymark TM Turbovap system (Hopkinton, MA) and redissolved in 100 laL HPLC eluent (eluent A). For LC-MS--MS analysis, 25-1JL aliquots were injected.
Chromatography
For the chromatographic separation, a narrow-bore Hypersil BDS C18 column (100 x 2.1 ram, 3 pro, Alltech, Deerfield, IL) and a guard column packed with the same material (7.5 x 2.1 mm) were used. The mobile phase was a 0.05M solution of ammonium acetate in HPLC-grade water (82.5%), methanol (8.75%), and acetonitrile (8.75%) (eluent A) or in methanol (41.2%), acetonitrile (41.2%), and HPLC-grade water (17.6%) (eluent B). After an isocratic part (100% A) of 10 rain, a linear gradient from 0% to 50% B within 17 rain was used, which was then held for 1 rain. After completion of the chromatographic run, the pump was programmed to regain its initial conditions within 0.5 min, and 5 min of reconditioning time was allowed.
MS
Electrospray ionisation (ESI) positive mass spectra (single MS and product ion scans) were acquired on a Q-TOF mass spectrometer. Conditions, optimized using continuous infusion of standard solutions (in eluent A) were ESI capillary voltage, 2700 V; cone voltage, 37 V; source temperature, 120~ and desolvation temperature, 350~ The ESI gas was nitrogen. For LC-MS-MS product ion analysis, the quadrupole was set to pass precursor ions of the selected mass into the hexapole collision cell (using argon as collision gas for CID), and product ion spectra were acquired with the TOF analyzer. The resolution of the quadrupole mass filter was set such that the peak width was 1.2 mass units at half height, and the collision energy was optimized at 25 eV. All TOF measurements were performed at high resolution settings [5000 fwhm (full width half mass) at mass 1500]; the TOF analyzer was "scanned" over m/z 100-320, with a 3-s integration time.
Quantitation
Quantitation was performed on computer reconstructed mass fragmentograms. These fragmentograms (see Table I for massto-charge ratio values used) are the Q-TOF alternative of a selected reaction monitoring process.
Specimen
A number of oral fluid samples from potential drug users (n = 15) were analyzed using this method. Oral fluid was collected using the non-acid-stimulated (plain) Sarstedt Salivette | (Sarstedt, Australia) by chewing the cotton roll for approximately 2 min. The oral fluid sample retrieved from the cotton roll was then transferred into sealed test tubes and stored until analysis at -20~ Figure 1 represents the chromatograms of an extract of an authentic oral fluid sample (sample 7 of Table II ). As can be seen from this chromatogram, all five compounds were well resolved. The retention times of benzoylecgonine, 2'-methylbenzoylecgonine, cocaine, cocaethylene, and 2'-methylcocaine were 5.7, 15.7, 21.2, 24.6, and 25.8 min, respectively. Clean chromatograms were obtained with no chemical background noise or interfering peaks. Figure 2 shows the MS-MS spectra of benzoylecgonine, cocaine, and cocaethylene. The collision-induced dissociation (CID) spectra of the protonated molecular ions (MS-MS) contained essentially one significant fragment ion at m/z 168 for benzoylecgonine, m/z 182 for cocaine, and the equivalent ion with m/z 196 for cocaethylene. For 2'-methylbenzoylecgonine and 2'-methylcocaine, two significant fragment ions were formed: 2'-methylbenzoylecgonine produced m/z 168 and 119 and 2'-methylcocaine gave m/z 182 and 119. These were also the fragment ions used for quantitation. 
Results and Discussion
LC-MS-MS
Linearity
The calibration curves proved linear over a range of 10-1000 I~g/L, using 7 calibrators at 10, 20, 50, 100, 200, 500, and 1000 IJg/L. Weighted linear regression (l/X) was used in an effort to account for data heteroscedasticity. A coefficient of determination of 0.995 or higher was obtained for all curves. The reproducibility (CV%) of the slope was < 4.9% (n = 7), indicating an excellent day-to-day match. The y-intercept for each calibration curve was virtually zero (the 95% confidence interval of the constant included zero in all cases). The following linearity data were achieved: benzoylecgonine y = 0.1382x + 0.0075; cocaine y = 0.1576x + 0.1007; and cocaethylene y = 0.1275 x + 0.1067.
Extraction recovery
The extraction recovery was determined at all of the calibration levels by comparison with nonextracted standards. The obtained results revealed a high (> 85% in all cases), reproducible (CV% < 7.4, n = 3), and fully concentration-independent recovery (mean 88.3%, CV% 5.1, measured at 7 concentration levels). Table III shows the precision data for the method presented. The data proved that the method performed well and complied to all precision requirements of a present-day bioanalytical method [i.e., precision well below 20% CV for limit of quantitation (LOQ) calibrators and below 15% for higher concentrations] (21).
Precision
Accuracy
For validation purposes, the accuracy for the three compounds was also determined using two oral fluid samples at concentrations of 20 and 500 lJg/L. The oral fluid samples for the accuracy investigation were independently prepared using different standard solutions. The obtained results were compared to the spiked concentrations, and the following results were obtained: at the 20 IJg/L level, values of 97.5%, 101.6%, and 100.3% for benzoylecgonine, cocaine, and cocaethylene, respectively, were found. At the 500 IJg/L level, the accuracy figures were 103.5%, 98.7%, and 97.8%, respectively.
Limit of detection (LOD) and LOQ
The LOD and LOQ were determined by analyzing decreasing concentrations of the compounds spiked in drug-free oral fluid. The LOD was established (n = 3) as the lowest concentration that produced a response of three times the noise level. It was 1 l~g/L [signal-to-noise ratio (s/n) > 3] for benzoylecgonine, cocaine, and cocaethylene. The LOQ was defined as the lowest concentration that could be quantitated with a precision of less than 20%. It was established as the lowest point of the calibration graph, being 10 IJg/L for benzoylecgonine, cocaine, and cocaethylene, respectively. As such, the method provided adequate sensitivity to allow correct quantitation within a concentration range suitable for its intended use (i.e., corroboration of drug abuse in a traffic, workplace, or detoxification program setting). It should be stressed that this can be achieved using only 100 IJL of sample.
Interference testing
Although LC-MS-MS is a very selective combination and interferences are unlikely, potential interference was tested. Several (68) common drug standards (alkaline or neutral compounds) dissolved in eluent at a concentration 25 times the upper calibrator concentration have been chromatographed and detected under the same conditions as the oral fluid samples. In no instance was an interference observed in the reconstructed ion chromatograms at the retention times of the analytes or the internal standards.
Results of the real samples
The practical use of the analytical method was evaluated and confirmed using a set of oral fluid samples voluntarily obtained from suspected or known drug users. Of the 15 samples investigated, 7 were positive for cocaine. An overview of the positive results can be found in Table II . In six out of seven samples, relatively low concentrations were found and, as expected, only the parent drug could be detected. Sample seven, on the other hand, was positive for cocaine and both metabolites, benzoylecgonine and cocaethylene.
Conclusions
A sensitive, reproducible, and selective method for the determination of cocaine, benzoylecgonine, and cocaethylene in oral fluid has been established using internal standardization with structurally related analogues of benzoylecgonine and cocaine, SPE, and LC-MS-MS. It allowed confirmation of the presence of cocaine and metabolites in concentrations substantially lower than the generally used cutoff levels in immunological screening methods, using only 100 IJL oral fluid, a volume which can realistically be sampled with the present day oral fluid collecting devices.
